New York City, U.S.A.):
Experiences in Breast Cancer In this paper I shall consider the broad field of breast pathology, non-neoplastic lesions, infections, and benign and malignant tumours, because some of the most interesting problems involve the twilight zone between frank cancer and benign lesions. Every patient presenting herself with a breast lesion is a possible cancer case. My personal experience has been unusual in the large number of cases, and the length of time, and was obtained through my connexion with the start, development and growth of the Breast Service of the Memorial Hospital, New York, over nearly thirty-three years until January 1, 1960 . It is based on 62,837 breast cases; 22,136 cancer cases; 40,701 benign cases; 10,108 radical mastectomies; 15,849 local excisions; and 5,499 radical mastectomies performed personally during the past forty years. During the past year, I performed 205 radical mastectomies and 454 local excisions.
The chief value of a large experience is the development of ideas which are justified by numbers. It is the small experience which makes us draw wrong conclusions. Furthermore, one has the opportunity of becoming familiar with the rarer cases. Although breast disease and pro-cedures are simple in comparison with many surgical problems, there are few things in medical practice about which the average clinician has less precise knowledge.
Survival After Radical Mastectomy
When Halsted performed his first radical mastectomy seventy years ago breast cancer was universally considered an incurable disease; he stated in 1894: "We rarely see a physician or surgeon who can testify to a single instance of positive cure of breast cancer." Thirteen years later, in 1907, Halsted reported his Johns Hopkins material as 30-8 % for his five-year over-all cure rate. In those days, the mortality from the radical operation was high and the material was much more advanced than it is to-day.
Cure rates began to improve. Fifteen years ago, the Maya Clinic (Harrington) reported a 51 -2 % five-year salvage on their operable material; the Memorial Hospital (Adair) 54-4%; and Karolinska Hospital (Stockholm) 54-4%. NOVEMBER By 1957, the Mayo Clinic (Berkson et al., 1957) reported a 64-2% five-year over-all salvage by radical mastectomy. Anglem (1960) of Boston reported a 66% fiveyear salvage. He and his colleagues have recently completed an interesting study (not yet published) of somewhat less than 300 cases. They showed that of the 26 patients who had radical mastectomies within a week of having noted the tumour, 23 patients (92%) survived five years or more, if they had an immediate radical mastectomy. Of 40 patients who were operated on within a month9 28 (70 %) survived five years. Of those operated on within three months, 62 % had five-year survival. And of those within six months, a 47 % survival. Those over six months, 50 % survival. The breakdown of figures into such small groups is questionable statistically; however, it does reveal a trend. This study by Anglem is impressive as it eloquently and dramatically points out the importance of quick decision on diagnosis and operation, and, by inference, the importance of recent intensive education of the public on the signs of cancer.
Each year in the United States there are 60,000 new cases of breast cancer. Until fifteen years ago, the salvage of the operable material was approximately 55 %, or 33,000 cases. Latest reports now indicate that there is an increase in the salvage of approximately 9 %, indicating that 5,400 additional patients are now being salvaged per year (Table I) . which included the internal mammary chain as a part of en bloc radical mastectomy. It is sometimes termed super-radical mastectomy. Beside the regular radical mastectomy, the costal cartilages, from costochondral junction to, and including, one centimetre of the edge of the sternum, and extending from the second to the fifth rib, inclusive, are included in one single flat chest-wall flap. The internal mammary lymph chain, together with the artery and vein, lie on the posterior surface of this portion of chest wall which is removed. This leaves a large window in the chest wall to be covered with a fascia lata graft. This procedure, added to an already timeconsuming radical operation, is responsible for many comments of disapproval. In the hands of the unskilled it would conceivably add to morbidity and mortality. About ten years ago, I placed Dr. Urban in the position at Memorial Hospital of developing his procedure. This he has done. Today, Margottini of Rome, Urban of New York, and Dahl Iversen of Copenhagen have had the major experience with this technique and its variants.
There have been several variations of the Urban operation, many of which are very satisfactory. Handley et al. (1956) have one preserving the pectoralis major muscle.
Urban now (April 1, 1960) tells me that he has performed 370 super-radical operations, with only two operative deaths-one due to a stroke, and the other to a perforated peptic ulcer. Of the 370 patients, 160 have been operated on over five years ago. Of these 160 cases: 33 % had involvement of internal mammary nodes, 55% had involvement of axillary nodes, and 28 % (44 cases) had both internal mammary and axillary involvement, of which 16 (36 3 %) have survived over five years. This is a remarkable achievement. Here are 16 of the 44 patients having both internal mammary and axillary involvement, cured. Ten years ago, before the day of super-radical mastectomy, they would surely have been doomed. This demonstrates well that there are no limits in extending the field of surgery. Who would have conceived, in the first place, that it would be possible to remove a large area of the chest wall and replace it successfully with a dense membrane -fascia lata ? And, in the second place, that the result of such an operation would give the incredible salvage of 1 out of 3 cases with involved internal mammary nodes. This achievement should make one question the statement by Haagensen that any patient having involvement of the internal mammary chain is not a fit patient for radical mastectomy. Such a patient may not be a proper candidate for a standard radical mastectomy, but is a proper case for superradical mastectomy.
Super-radical mastectomy is making a substantial contribution to the treatment of our most common type of human cancer. It would not have been possible without marked advances in anaesthesia. Rather than apply this operation to every case of breast cancer, it is applied to only thosewith the primary in the medial half of the breast, nearest to the internal mammary chain; and also those with the primary in the nipple area, from which the lymphatic spread is in every direction. As the internal mammary nodes extend in width over rather a broad zone, a wide chest-wall flap must be removed, otherwise a node may remain. Therein lies the danger of trying to abbreviate this part of the procedure.
One of the most impressive accomplishments of Urban's experience is that of local recurrence in those cases of carcinoma originating in the medial half and central nipple area. By the complete removal of the internal mammary chain, the local recurrence caused by extension upward into the skin from the involved internal mammary chain is largely eliminated. His overall recurrence rate is only 8 %; for comparison, another wellknown report on radical mastectomy has 13 %. "When you consider only medial and central lesions, our rate was 8 *4 % and theirs 23 %. Then, if we consider parasternal recurrence as the first sign of recurrent cancer, we had none in our group. It looks as if we have dropped our local recurrence rate to one-third of what might be anticipated with straight radical mastectomy, and we have increased our salvage by about 10% over what we might anticipate had the same material been treated by a straight radical with the customary post-operative X-ray therapy."
Developments in Pessimism
It is not yet widely recognized that there is a definite trend in the improvement of results by surgical therapy. And there is also not sufficient comprehension by the medical profession of the importance of educating the public on cancer signs. Certain pessimistic trends have recently been developing, and are now beginning to reach serious dimensions; if pursued they will cost many lives. They are as follows:
(1) Simple mastectomy and post-operative irradiation.-It could only have been due to dissatisfaction in the end-results of radical mastectomy that led McWhirter to his conclusion that simple mastectomy, followed by X-ray therapy, was preferable. This left the way open for incompetent surgeons, who hesitated at big operations, to choose the simple procedure. It also left behind axillary disease in practically half the patients (47 5 %). We would be happy to embrace this theory, if it works. It would so simplify our problems. However, my studies of the effectiveness of irradiation therapy in axillary disease have left me greatly disappointed. The crux of simple mastectomy and post-operative irradiation is whether irradiation can effectively destroy axillary disease.
Microscopic studies of axillary disease following irradiation therapy show much of the disease to be viable.
(2) Simple mastectomy alone.-In the U.S.A., perhaps the greatest exponent of simple mastectomy only is Dr. George Crile, Jr. His method is to perform simple mastectomy and then wait and, if the axilla subsequently becomes clinically involved, perform radical mastectomy. It is often impossible, clinically, to ascertain if there is axillary involvement. An axillary node may be large, but only hyperplastic; or a node may be involved but so small or so high in the axilla that it is not palpable. By this method of waiting I fear that the opportunity to save many lives may be lost.
(3) "Showers" versus more orderly metastasis. -Some articles suggest that metastasis takes place by simultaneous "showers" of cancer cells to wide areas of lymph nodes. They infer that this is the reason for failure of cure. In most cases, the cancer cells float from the primary tumour in an orderly way, by the lymphatics to the perilymphatic spaces of the lower chain of axillary or internal mammary nodes. After the perilymphatic spaces are filled, the cancer cells fill the medulla of the lymph node, travelling from one node to the next, until they reach nodes about the falciform ligament and the supraclavicular space. The process is an orderly one, and does not involve all the axillary nodes simultaneously. This can be proven by a recent study of my last 200 cases. It showed that of the 95 patients having axillary involvement, 89 (44 5 %) had level I involved; 68 (34%) level II involved; and 49 (24 5 %) had involvement of level III. If metastasis took place in "showers," all three levels would be involved simultaneously and in equal percentage.
(4) Vein wall invasion.-There has recently appeared a re-emphasis on the frequency of cancer invasion of the vein wall, as another reason for lack of a high cure rate. It is true that multiple section studies of the primary tumour and surrounding areas at times demonstrate invasion of the vein wall. This could account for blood stream contamination by freely floating cancer cells. Willis (1952) stated that "neoplastic penetration into the venous blood stream is present in greater or less degree in at least 50% of all fatal cases of malignant growth". Dukes and Bussey (1958) stated that in a series of 197 cases of cancer of the bowel with venous invasion, 35*4% survived for five years.
The fact that there are freely floating cancer cells does not at all signify that these cells will graft themselves on to other tissues and survive. Everything points to the non-survival of these cancer cells in the blood stream except in those advanced cases with a fatal outcome. Engel! (1959) found that 51 % of those surviving five years or more were originally reported as having circulating tumour cells at the time of operation and concluded that the finding of these cells has little importance, the cells having been destroyed in the blood stream.
(5) Reports of small numbers of cases.-There have been several reports of end-results in treatment of breast cancer where few cases were treated. Deaton and Bradshaw (1951) reported 30 cases treated by simple mastectomy and 54 cases by radical mastectomy. Barnett (1959) reported 19 cases of simple and 74 of radical mastectomy. There are many other reports which are unsound statistically on account of small numbers. Recently, Smith and Meyer (1959) came to the incredible conclusion that "neither the fivenor ten-year survival rates were affected by the type of operation, the duration of the tumour, or the skill of the surgeon". Their conclusion was reached by comparing the endresults of 11 cases treated by local excision only, 84 cases treated by simple mastectomy, and 324 cases treated by radical mastectomy. If their conclusions were correct, there would never be a reason for more than a local excision of the tumour. Historically, we know that seventy years ago, before radical mastectomy was developed, surgical cure was not even a practical matter. To-day, the medical profession recognizes that cancer of the breast is one of the most curable of all cancers.
(6) Down-grading of proper operation.-As a result of disappointment in the end-results of radical mastectomy coupled with "trick" statistical reports of good end-results by minimum surgical procedures, and misinterpretation of the significance of cancer cells floating in the blood stream, we are now going through a temporary and unfortunate phase. It seems to be a popular pastime to down-grade early diagnosis and early adequate treatment. This phase will eventually pass.
Encouragement
Never before have we had so much authoritative evidence that patients are coming earlier than previously. Those patients having axillary involvement. are less in number than previously; axillary involvement at levels I, II, and III, repre-sents a diminished percentage. The development of super-radical mastectomy has cut local recurrences to one-third. Finally, the cure rate is definitely higher than ten to fifteen years ago.
Summary
The super-radical mastectomy is discussed. It is used particularly in those cases involving the medial quadrants and the nipple area. Superradical mastectomy has added approximately 10% to the over-all five-year salvage, as well as materially cutting down on chest wall recurrence. 33 % of cases having involvement of the internal mammary chain have a five-year survival.
Several reports have recently appeared of an unwarranted pessimistic character, indicating that no matter what procedure is carried out, simple or radical mastectomy, whether by men of recognized skill or not, whether metastasis is by widespread "showers" or the more orderly and usual processes, the results are approximately the same-bad.
In contrast to this pessimism is the evidence that the public is becoming more aware of cancer signs and coming earlier to the doctor; that there is less axillary involvement; and that the over-all results of radical surgery have been improving. In the United States, the 9 % improvement of the past fifteen years should result in salvaging some 5,400 lives per year. This may appear to be slow progress, but we have waited a long time for this encouragement. Halsted's 1907 report of 30% salvage has been doubled in fifty-two years and there is every reason to believe the improvement will continue-even though slowly. We should continue to emphasize education of the public on cancer signs, early diagnosis and immediate and adequate surgical treatment. Therein lie our chief hopes for improved results in breast cancer. Some Complexities in the Treatment of Carcinoma of the Breast The success or failure of treatment of carcinoma of the breast depends on a number of complicated reactions. Crude survival rates conceal many refinements of biological behaviour. What they chiefly reveal is that the result depends on the material treated (Fig. 1) . When rigid 'treatment rules are applied to a highly varied group of patients with apparent early breast tumours, the survival rate may vary little between radical mastectomy and local mastectomy and irradiation. Local excision only of the tumour with irradiation has shown results no worse than some of those obtained with more radical operations (Baclesse et al., 1960) . My purpose is not to advocate any particular treatment, but merely to indicate a few of the concealed complexities.
The benefits of surgery in suitable cases are so great that'judgment is continually swayed in its favour and towards its extension to more radical procedures often in just those cases in which it cannot hope to succeed and is likely to do harm. Under these circumstances the overall result may be improved merely by adopting more conservative surgery. If at the same time there is an improvement both in the radiotherapy and in the material presenting for treatment, it may appear as though a real advance has been made. In some centres where axillary dissection has been abandoned, perhaps what was wanted was merely better judgment in choosing the right moments for radical operations.
In prescribing treatment we have to rely a good deal on the inaccuracies of clinical staging but fortunately this is to some extent correlated with histological grade. Survival following surgery depends more on the grade of malignancy of the tumour than on any other single factor such as early diagnosis or involvement of axillary nodes (Smithers, 1958) .
Failure following excision is not the same thing as not succeeding. The patient is generally made worse and may have been deprived of the benefits of an alternative treatment as well. Good surgery no longer tolerates high local recurrence rates in the way it accepted them in the past; it has now to consider much more carefully what responsibility it should take for the appearance of distant metastases.
The evidence for the surgical promotion both of local overgrowth and of tumour dissemination is overwhelming. Charles Ryall wrote an excellent account of the clinical evidence from my hospital in 1907. Many people, particularly the French, have been giving accounts of the experimental evidence since the work of Marie and Clunet in 1910. Roussy et al., (1935) discussed the part played by removal of implanted tumours in the production of metastases and maintained that extirpation of a tumour had not only a local effect but a distant one as well and that in some circumstances the removal of a tumour might favour the proliferation of other tumour cells remaining in the organism. Schatten (1958), using two tumours in mice implanted into a limb, performed amputations when the tumours were approximately 1-5 cm in size about twenty-one days after implant. He showed, with one tumour, that the frequency of metastasis was increased whether the normal leg or the tumour-bearing leg was amputated, and with-the other that this only occurred when the tumourbearing leg was removed. Even more striking, however, was the fact that removal of the leg bearing the implanted tumour enhanced the growth rate of metastases. There was little difference between groups sacrificed on the twenty-first or twenty-eighth day in the size of the lung metastases noted in two control series, one without any operation and one in which the normal leg had been amputated. In the groups in which the animals were sacrificed on the twentyfirst and twenty-eighth day after amputation of the tumour-bearing limbs, however, larger metastases were found on the twenty-first day and larger still on the twenty-eighth day, showing that they were growing rapidly.
Much further interesting work bearing on this issue has been done, for example by Fisher and Fisher (1959) who showed that both laparotomy and liver manipulation increased the number of metastases occurring after the injection of tumour cells. There has been a series of most interesting observations of this kind emanating from Warren Cole's department in the University of Illinois (Buinauskas et al., 1958) an excellent account of which was reported recently in a Hunterian lecture at the Royal College of Surgeons by Griffiths (1960) . There is a great deal of this kind of evidence accumulating at the present time.
There is also evidence of other kinds, for example, the correlation between prognosis and lymph node reactivity, stressed to-day by Black and Speer (1960) but also reported a good many years ago, by Murphy in 1926 for example. In patients who survive more than five years the reactive patterns found in their lymph nodes seem to be predominantly similar to those seen in response to antigenic stimulation. These observations raise many interesting questions as yet unanswered. Richard Stark has demonstrated the enhancing effect of surgical ablation of regional lymph nodes on homografts of skin and reported a case at the last homograft conference where a skin graft persisted four times as long on the arm of a woman following a radical mastectomy as did another graft on the opposite side (Stark, 1960) .
We seem more prepared to accept the fact that there are many complications associated with the actions of radiotherapy and of hormone therapy than we are to believe in the complex effects of surgery. There has in the past been a grand simplicity about the aims of surgery in the treatment of patients with neoplastic disease. We are now tending to remember once more that we are dealing with a difficult set of tumour-host relationships which we can easily disturb to the patient's disadvantage (Table I) . (1) Significance of post-operative increase in "tumour cells" in blood.
(2) Risks of enhancement of local tumour growth by trauma.
(3) Effects of primary tumour on growth of disseminated cells. (4) Role of regional lymphatics in control of tumour growth.
Radiotherapy, like surgery, can promote the development of distant metastases by a humoral effect, as Kaplan and his colleagues have shown (Kaplan and Murphy, 1949; von Essen and Kaplan, 1952) , but it does not normally promote local overgrowth as surgery may do. In fact it supplies growth restraint even when it fails, not growth enhancement. It cannot be successful for patients with carcinoma of the breast in the regular way that surgery is under the best conditions. It is, however, much better than un-successful surgery. It can also make successful surgery possible. It is becoming a greater not a lesser responsibility to decide to operate in a doubtfully operable case of breast carcinoma.
Hormone therapy is the natural treatment for re-establishing control in those neoplastic diseases which affect hormone-controlled organs.
It depends for success on finding tumour cells still competent to respond to a particular chemical influence. This competence depends on differentiation and tends to be lost during progression in anaplasia. Timing in the application of such treatment may therefore be of great importance. The study of spontaneous regression in breast tumours (Table II; Smithers, 1952) suggests that early treatment may at times produce regressions lasting many years. (1952) In summary, I think the following suggestions now demand careful consideration:
(1) The level of discussion in the controversy about the relative merits of "radical mastectomy", and "local mastectomy and radiotherapy" has been too low, and the figures presented in evidence too disconnected, for it to have been of any real benefit to us in deciding between them as generally applicable methods in early cases.
(2) A simple statement such as "I do a radical mastectomy for all patients with breast cancer in Stages 1 and 2" no longer does real justice to a delicate matter of clinical judgment.
(3) It does not matter how soon patients with Grade III tumours of the breast are operated on or how early they appear clinically; nearly all of them will be dead in two or three years.
(4) In carcinoma of the breast post-operative irradiation to a part treated surgically is either unnecessary or a confession of failure in a patient who may have suffered already from the treatment regime selected.
(5) Radiotherapy which fails to eradicate the disease usually helps, but surgery which fails generally makes matters worse. While surgery is more regularly successful than radiotherapy, especially with Grade I tumours, irradiation alone or in combination can achieve excellent results at times. The decisions to be taken in borderline cases will continue to be fraught with difficulty so long as we have inadequate information about tumour grade.
(6) We are dealing with a complicated tumourhost relationship in which such things as the presence, the size and the rate of growth of the primary, or the absence of the regional lymph nodes, may possibly be important influences on the development and rate of growth of bloodborne metastases.
(7) For progress in the treatment of patients with carcinoma of the breast we need to develop methods of appraisal of the biological behaviour of each tumour in each patient. The application of rigid treatment rules under highly individual circumstances, based solely on our uncertain clinical judgment of the stage of advancement of the disease before us, should not really satisfy any of us much longer.
Mr. Hedley Atkins (London):
Fallibility in Carcinoma of the Breast The following observations are based on a study of 3,000 cases of breast disease seen at the Breast Clinic at Guy's Hospital since 1956. The theme of this discourse is the fallibility of clinical appraisal and of histological classification. Modifications in practice which derive from a recognition of this fallibility are suggested.
First, in regard to diagnosis, it is unfortunately true that many years of experience and the most careful clinical examination cannot obviate error. In the last 69 cases confidently diagnosed as cancer, 6 turned out to be innocent; out of 33 cases confidently diagnosed as innocent, one turned out to be malignant. In a further 47 patients in whom the diagnosis was uncertain, the percentage of error in the putative diagnosis was even higher. Owing to the practice in this clinic of performing a preliminary excision of the lump before undertaking radical mastectomy, no patient suffered from this example of clinical ineptitude. About 25% of patients have their lumps submitted to examination by frozen section technique before mastectomy is performed, and in a further 5 to 10% the lump is examined with the naked eye.
In the absence of facilities for frozen section of a doubtful lump, no anxiety need be entertained if there is a delay of many days while waiting for the paraffin embedded blocks to be examined. The five-year survival rate in 50 such patients in whom the interval between excision of the lump and definitive treatment varied between fortyeight hours and several weeks, with a modal interval of three to four days, was 86 %. This fiveyear survival rate was the best of any category in the series.
If there is difficulty in the clinical diagnosis of lumps in the breast, there is even greater difficulty in diagnosing the cause of a discharge from the nipple. If the duct from which the discharge is emanating can be identified, then the operation of microdochectomy should be performed. In certain other cases in older women a mastectomy should be performed. Just as is the diagnosis, so the clinical staging of breast cancer is open to error. The observer variation in deciding whether glands in the axilla are implicated is so considerable as to make clinical staging nearly valueless. Even histological staging on the mastectomy specimen is useless unless a uniform technique is used for examining these specimens. The five-year survival rate on Stage II cancers at the Breast Clinic is 59 %. This is about 20 % better than the usually published survivals from all over the world. The reason for this surprising discrep-ancy is not that our treatment is more successful, but that our staging is more meticulous and we employ a worker who spends a great deal of time in examining the glands in the axilla of mastectomy specimens. In this way our Stage II category consists of numbers of patients who, following a routine examination of the mastectomy specimen, would have been categorized as Stage I and would have appeared as Stage I cases in the statistics of other hospitals.
A consideration of these sources of error suggests the following conclusions:
(I) When there is the slightest doubt about the diagnosis, histological confirmation should be sought before proceeding to mastectomy.
(2) A discharge from the nipple should be operated upon when the offending duct can be identified as well as in certain cases when identification is not possible.
(3) A comparison of results between different centres is fruitless. (I) A response to adrenalectomy is predicted if the average total urinary excretion of the cestrogen metabolites-aestriol, cestrone and cestradiol-is in excess of 3 micrograms a day. No response is expected when the aestrogen excretion is less than 3 micrograms a day.
(2) A biopsy is taken from the normal breast and assessed as stimulated or unstimulated according to the histological appearances. A stimulated breast has lobules of average development, as is shown in Fig. lA. In Fig. 1B an unstimulated breast is seen, where lobular involution is complete so that only ducts remain. A response to hypophysectomy is expected only if the normal breast tissue can be classified as stimulated. The details of these methods have been described by Jull et al. (1959) .
Four classes of patients are possible: aestrogen excretion high (>3,ug) or low (<3,ug), and the normal breast tissue either stimulated or unstimulated (Table I) In the first group, where the cestrogen level is low and the breast is unstimulated, patients have been submitted to adrenalectomy or hypophysectomy, although no response was expected by our criteria. This is, therefore, a negative control group. In the other three groups the operation of choice has been performed whenever possible. The results on 18 postmenopausal patients, evaluated so far, are shown in Table II . 15 patients were subjected to adrenalectomy. In 10 of these a remission of malignant growth was expected and this was realized in 7. In 5 patients a poor result was forecast and in 4 of these the progress of the disease appeared uninfluenced by the operation. One patient improved in this latter group, contrary to our expectation.
Only 3 patients were subjected to hypophysectomy. In 2, regression of the cancer was expected and observed, while in one case a poor response was forecast and in fact no remission occurred.
Thus, the expected result was obtained in 78 % of the patients. When selection is random, a positive result occurs in about 40(% of patients and there are no means of finding out those who will not respond.
The same criteria may be applied to decide whether hypophysectomy will produce further improvement after adrenalectomy. Our few results are shown in Table III . A response to the operation was expected in 4 patients and was observed in 3, while in a single case where a poor result was forecast the operation gave no apparent benefit to the patient. Hypophysectomy applied at random after adrenalectomy gives a response rate of about 25 %.
Tlhe present overall successful prognosis rate of about 80%, using our criteria, is encouraging. 100% success cannot be expected because this method is based on the evaluation and removal of certain hormones which influence the breast, and there is always a proportion of tumours which are independent of these hormones. However, if the present success of prediction is maintained the method may find application in the selection of those patients expected to benefit from endocrine ablation.
